🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
the purpose of this study is: * To assess the effect of BIA 5 1058 400 mg ...
Status
Completed
Location
PAREXEL International - Early Phase Clinical Unit - Berlin
Start Date
2018-02-06
Trial ID
NCT04991207
Treatments Being Tested
Bosentan has been largely used in the treatment of pulmonary hypertension (...
Status
Terminated
Location
Respiratory Unit, Fondazione S.Maugeri
Start Date
2008-05
Trial ID
NCT00679068
Treatments Being Tested
COMPASS-2 is a Phase 4, prospective, randomized, double-blind, placebo-cont...
Status
Completed
Location
Multiple Locations
Start Date
2006-05
Trial ID
NCT00303459
This is a Phase 1, open-label, fixed-sequence, 2-part DDI study. Subjects w...
Status
Completed
Location
Site 1
Start Date
2023-01-03
Trial ID
NCT05657613
Hypothesis: The endothelin-1 receptor antagonist, bosentan when added to th...
Status
Terminated
Location
University of Connecticut Health Center
Start Date
2008-12
Trial ID
NCT00815347
Supine hypertension is a common problem that affects at least 50% of patien...
Status
Completed
Location
Vanderbilt University
Start Date
2001-01
Trial ID
NCT00223717
Treatments Being Tested
The effect of bosentan on digital ulcers (DU) was studied in two randomized...
Status
Completed
Location
VUmc
Start Date
2011-03-31
Trial ID
NCT01395732
Treatments Being Tested
The present trial investigates a possible use of oral bosentan, which is cu...
Status
Completed
Location
University of Alabama-Birmingham
Start Date
2004-04
Trial ID
NCT00091715
Volume overload due to left-to-right shunting in patients with atrial septa...
Status
Completed
Location
University Hospitals Leuven
Start Date
2010-10
Trial ID
NCT01218607